• Explore /
  • Poster
  • / Nivolumab (Nivo) and ipilimumab (Ipi) in combination with radiotherapy (RT) in high-risk patients (pts) with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN).

Nivolumab (Nivo) and ipilimumab (Ipi) in combination with radiotherapy (RT) in high-risk patients (pts) with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN).

Abstract Poster

Authors

null

Jennifer Maria Johnson

Thomas Jefferson University, Department of Medical Oncology, Philadelphia, PA

Jennifer Maria Johnson , Voichita Bar Ad , Emily Lorber , Dawn Poller , Gregor Manukian , Adam Luginbuhl , Joseph M. Curry , David M. Cognetti , Scott W. Keith , Rita Susan Axelrod , Ulrich Rodeck , Larry Harshyne , Athanassios Argiris

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Local-Regional Disease

Clinical Trial Registration Number

NCT03162731

Citation

J Clin Oncol 38: 2020 (suppl; abstr 6577)

DOI

10.1200/JCO.2020.38.15_suppl.6577

Abstract #

6577

Poster Bd #

238

Abstract Disclosures

Similar Posters

First Author: Geoffrey Thomas Gibney

First Author: Lorenzo Pilla

First Author: Yaacov Richard Lawrence

First Author: Charlee Nardin